• About Us
    • Overview
    • Education
    • Mission & History
    • Board of Directors
    • The Campus
    • Careers
  • Our Achievements
    • Overview
    • Cancer
    • Technology
    • Education
    • Our Planet
    • Health & Medicine
    • Physical World
  • Get Involved
    • Overview
    • Partners in Science
    • Estate & Planned Giving
    • Attend an Event
    • Gift Opportunities
  • News & Media
    • Overview
    • News & Media Archive
    • Coronavirus
    • Feature Stories
    • News Releases
    • In The News
    • Video Gallery
    • Ad Campaigns
    • Celebrating Great Minds
  • Blog
  • Contact
  • Donate
Donate
Donate
About Us tri
About Us Overview
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
About Us

Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.

Our Achievements tri
Our Achievements Overview
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Our Achievements

The Weizmann Institute’s fundamental research has led to discoveries and applications with a major impact on the scientific community and on the quality of life for millions worldwide.

Get Involved tri
Get Involved Overview
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
Get Involved

Join a community of dedicated people who share the Weizmann Institute’s commitment to shaping a better world through science.

News & Media tri
News & Media Overview
  • News & Media Archive
  • Coronavirus
  • Feature Stories
  • News Releases
  • In The News
  • Video Gallery
  • Ad Campaigns
  • Celebrating Great Minds
News & Media

Learn about the Weizmann Institute’s latest groundbreaking discoveries and the American Committee’s activities across the country.

Blog tri
  • The Curiosity Review
Blog

Popular science for the curious-minded: The Curiosity Review brings discovery to life.

Contact

Search Results

  • SEARCH BY KEYWORD
  • SEARCH BY TAG
View Articles by Tag:
  • View Articles by Tag
  • Algorithims (6)
  • Alternative energy (27)
  • Alzheimers (44)
  • Archaeology (37)
  • Artificial intelligence (20)
  • Astrophysics (106)
  • Autism (22)
  • Awards (117)
  • Bacteria (107)
  • Behavior (9)
  • Biochemistry (100)
  • Biofuel (7)
  • Biology (308)
  • Biomolecular sciences (7)
  • Blood (43)
  • Brain (175)
  • Cancer (163)
  • Cancer treatment (127)
  • Central nervous system (9)
  • Chemistry (78)
  • Children (7)
  • Circadian clock (1)
  • Climate change (72)
  • Clinical trials (40)
  • Collaborations (15)
  • Community (278)
  • Computers (73)
  • Copaxone (12)
  • Coronavirus (7)
  • Culture (357)
  • Diabetes (32)
  • Earth (71)
  • Education (154)
  • Environment (92)
  • Enzymes (29)
  • Evolution (89)
  • Fertility (20)
  • Fungus (4)
  • Genetics (108)
  • Genomics (3)
  • Heart (4)
  • Heart disease (2)
  • Humanity (82)
  • Immune system (149)
  • Immunology (10)
  • Immunotherapy (34)
  • Inflammation (19)
  • Leadership (111)
  • Leukemia (12)
  • Materials (44)
  • Mathematics (62)
  • Medicine (83)
  • Memory (39)
  • Mental health (58)
  • Metabolism (51)
  • Microbiology (2)
  • Microbiome (10)
  • Molecular cell biology (9)
  • Molecular genetics (61)
  • Multiple sclerosis (12)
  • Nanoscience (33)
  • Nature (4)
  • Neurobiology (2)
  • Neuroscience (207)
  • Nutrition (72)
  • Optics (31)
  • Organs (11)
  • Parkinsons (11)
  • Personalized medicine (5)
  • Philanthropy (146)
  • Physics (136)
  • Plants (56)
  • Proteins (96)
  • Quantum computer (3)
  • Quantum physics (2)
  • Quantum theory (34)
  • Robots (8)
  • Security (21)
  • Senses (115)
  • Sensors (8)
  • Smoking (1)
  • Solar power (19)
  • Space (108)
  • Stem cells (48)
  • Technology (206)
  • Vaccine (40)
  • Virus (135)
  • Water (40)
  • Weather (1)
  • Women (115)
  • World hunger (17)
Filter by Time:
  • All
  • Past Day
  • Past Week
  • Past Month
  • Past Year
  • Past Three Years
Clear Filters

163 results for Cancer

Lymphedema: What It is, What's Being Done About It, and How You Can Help
Lymphedema: What It is, What's Being Done About It, and How You Can Help

https://www.weizmann-usa.org/news-media/feature-stories/lymphedema-what-it-is-what-s-being-done-about-it-and-how-you-can-help/

Mar 11, 2016... Kathy Bates for World Lymphedema Day
“There is no cure for lymphedema,” states the Mayo Clinic. That’s one reason people all over the world are coming together to raise awareness of this condition – including Oscar-winning actor Kathy Bates, who developed it after breast cancer surgery.
Lymphedema is swelling, typically in the arms and legs, and affects as many as 10 million Americans, many of them cancer survivors like Ms. Bates. In fact, according to the Mayo Clinic, the condition is “most commonly caused by the removal of or damage to your lymph nodes as a part of cancer treatment.”

TAGS: Culture, Education, Cancer, Blood

Research on Aging at the Weizmann Institute
Research on Aging at the Weizmann Institute

https://www.weizmann-usa.org/news-media/feature-stories/research-on-aging-at-the-weizmann-institute/

Aug 01, 2012... According to the World Health Organization (WHO), in 1900, the global average life span was 31 years of age. By 2030, in highly developed places such as the U.S., average life expectancy at birth is expected to be around 85. And while wisdom may come with age, so do many unwanted issues, such as poor physical and mental health. In addition, an aging population takes a toll on society: older people are often harder to treat medically; it can be more challenging to get around, either on foot or by driving; and general quality of life may be reduced.

TAGS: Cancer, Humanity, Cancer treatment, Clinical trials, Alzheimers

Kathy Bates: My Battle with Lymphedema
Kathy Bates: My Battle with Lymphedema

https://www.weizmann-usa.org/news-media/in-the-news/kathy-bates-my-battle-with-lymphedema/

Jun 24, 2015... Shortly after I had a double mastectomy, I got lymphedema in my arms. I was devastated. I knew going in what it was, and I was terrified.
Put very simply, the lymphatic system provides cells with nutrients and acts as a means of waste removal. We need it to survive. However, the same system will also carry cancer cells to other parts of the body, which is called metastasis. Cancer cells get trapped in lymph nodes and cause secondary tumors, which is why surgeons will err on the side of caution to keep the cancer from coming back. Curing cancer is their focus after all.

TAGS: Cancer, Biology, Cancer treatment, Philanthropy, Blood

Israeli Researchers' Discovery Could Lead to New Type of Cancer Treatment
Israeli Researchers' Discovery Could Lead to New Type of Cancer Treatment

https://www.weizmann-usa.org/news-media/in-the-news/israeli-researchers-discovery-could-lead-to-new-type-of-cancer-treatment/

Jul 12, 2012... Prof. Atan Gross in his laboratory at the Weizmann Institute in Rehovot. Nir Keidor
Israeli researchers have identified a new mechanism for inducing the programmed death of cells, a discovery that could be used to develop novel methods for treating cancer.
The discovery began with the identification of a protein, mitochondrial carrier homolog 2, in human mitochondria. Mitochondria are the cells' "power plants," converting nutrients into the chemical energy required for the cell's ongoing operations.

TAGS: Cancer, Cancer treatment

Teaming Up to Defeat Prostate Cancer
Teaming Up to Defeat Prostate Cancer

https://www.weizmann-usa.org/news-media/feature-stories/teaming-up-to-defeat-prostate-cancer/

May 28, 2015... Prostate cancer is the second most common type of cancer – and the second leading cause of cancer-related deaths – among American men. According to the Centers for Disease Control and Prevention (CDC), one in six men will be diagnosed with prostate cancer during his lifetime.
Three leading researchers in this field – Prof. Avigdor Scherz of the Department of Plant Sciences at Israel’s Weizmann Institute of Science; Dr. Peter Scardino, Chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City; and Dr. Peter Schulam, Chair of the Department of Urology at the Yale School of Medicine, New Haven – agree that safer, more effective detection methods and treatments are needed for the more than 240,000 men diagnosed with prostate cancer each year. Speaking at an event co-sponsored by the New York Region of the American Committee for the Weizmann Institute of Science and the Association of Yale Alumni in Medicine, the researchers described the current state of prostate cancer diagnosis and therapy and discussed their collaboration on a highly promising new treatment.

TAGS: Cancer, Cancer treatment, Clinical trials

Prof. Yardena Samuels: Breakthroughs in Cancer Diagnosis Research
Prof. Yardena Samuels: Breakthroughs in Cancer Diagnosis Research

https://www.weizmann-usa.org/news-media/video-gallery/prof-yardena-samuels-breakthroughs-in-cancer-diagnosis-research/

May 25, 2017... Prof. Yardena Samuels: Breakthroughs in Cancer Diagnosis Research

TAGS: Genetics, Cancer, Molecular genetics, Cancer treatment

Science Tips, June 2015
Science Tips, June 2015

https://www.weizmann-usa.org/news-media/news-releases/science-tips-june-2015/

Jun 29, 2015... Normal human colonic crypts. SMOC-2 expression (red) in the colonic stem cells demonstrates that these cells are localized in the bottoms of the crypts. Bars represent 100 micrometers (left) and 50 micrometers (right)
Recent Weizmann Institute studies are revealing a complex picture of cancer progression in which certain genes that drive tumor growth in the earlier stages get suppressed in later stages – taking a step back to move forward. Published in Oncogene, current research from the lab of Prof. Avri Ben-Ze’ev of the Department of Molecular Cell Biology suggests that the tumor cells at the invasive front of later-stage human colorectal cancer may take an even bigger step back: Some of their gene expression patterns are shared with those of healthy intestinal stem cells.

TAGS: Astrophysics, Neuroscience, Cancer, Biology, Cancer treatment, Senses

Breakthrough Cancer Cure has Deep Israeli Roots
Breakthrough Cancer Cure has Deep Israeli Roots

https://www.weizmann-usa.org/news-media/in-the-news/breakthrough-cancer-cure-has-deep-israeli-roots/

Feb 17, 2016... Illustrative photo of a doctor with a cancer patient (cancer patient image via Shutterstock)
A breakthrough cancer study in which patients suffering from a form of leukemia saw their diseases go into remission after they were treated with genetically modified T-cells has deep roots in Israel.
One of the first in the world to work on the innovative adaptive immunotherapy technique to treat cancer, which was hailed Tuesday worldwide as a potentially “extraordinary” development, was Weizmann University Professor Zelig Eshhar. Speaking Wednesday on Israel Radio, Eshhar said he was very heartened to hear about the results of the study at the University of Pennsylvania.

TAGS: Cancer, Cancer treatment, Immunotherapy, Leukemia

Weizmann Institute's Mathematical Model May Lead to Safer Chemotherapy
Weizmann Institute's Mathematical Model May Lead to Safer Chemotherapy

https://www.weizmann-usa.org/news-media/news-releases/weizmann-institute-s-mathematical-model-may-lead-to-safer-chemotherapy/

Sep 14, 2012... REHOVOT, ISRAEL—September 14, 2012—Cancer chemotherapy can be a life-saver, but it is fraught with severe side effects, among them an increased risk of infection. Until now, the major criterion for assessing this risk has been the blood cell count: if the number of white blood cells falls below a critical threshold, the risk of infection is thought to be high. A new model built by Weizmann Institute of Science mathematicians, in collaboration with physicians from the Meir Medical Center in Kfar Saba, Israel, and the Hoffmann-La Roche research center in Basel, Switzerland, suggests that for proper risk assessment, it is essential to evaluate not only the quantity of these blood cells, but also their quality, which varies from one person to another.

TAGS: Medicine, Cancer, Cancer treatment, Bacteria, Mathematics

T-cell Therapies for Cancer: From Outsider to Pharmaceutical Darling
T-cell Therapies for Cancer: From Outsider to Pharmaceutical Darling

https://www.weizmann-usa.org/news-media/in-the-news/t-cell-therapies-for-cancer-from-outsider-to-pharmaceutical-darling/

Aug 24, 2016... Source: Dr Steven A Rosenberg, MD/PhD. Micrograph of a group of T cells attacking a tumour cell.
Robert Hershberg, chief scientific officer at New Jersey-based biotechnology company Celgene, recalls the first time he heard about engineered T cells. It was back in 2002 when he was working at a company called Corixa in Seattle, Washington. “There was a discussion about these strange molecules called T bodies and we all thought it was a little bit hare-brained and I remember thinking… it’s going to be a real longshot.”

TAGS: Cancer, Cancer treatment, Immunotherapy

First 1 2 3 4 5 6 7 8 9 10 ... Last
Back Next
SHARE

Our Achievements

Learn more about remarkable Weizmann Institute achievements that are enhancing and transforming our lives.

Learn More

Support Our Flagship Projects

Help us accelerate exciting initiatives in three forward-looking fields: neuroscience, physics, and artificial intelligence.

Learn More

Newsletter

Get the latest news and breakthroughs from the Weizmann Institute of Science.

About Us
  • Education
  • Mission & History
  • Board of Directors
  • The Campus
  • Careers
Our Achievements
  • Cancer
  • Technology
  • Education
  • Our Planet
  • Health & Medicine
  • Physical World
Get Involved
  • Partners in Science
  • Estate & Planned Giving
  • Attend an Event
  • Gift Opportunities
News & Media Blog: Curiosity Review Donate Now Contact Us
Privacy Policy Gift Acceptance Policy Financial Information

©2023 American Committee for the Weizmann Institute of Science

Charity Navigator

FOR THE FOURTH CONSECUTIVE YEAR